| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.099 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |